Sevirumab, CAS 138660-96-5

Product Description: Sevirumab (MSL-109) is a human IgG1 neutralizing monoclonal antibody against cytomegalovirus (CMV). Sevirumab recognizes CMV gH complexes and inhibits CMV replication with an EC50 of 0.3 μg/mL[1][2].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Nokta M, et al. Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication. Antiviral Res. 1994 May;24(1):17-26./[2]Fouts AE, et al. Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109. Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8209-14.

CAS Number: 138660-96-5

Molecular Weight: N/A

Research Area: Infection

Solubility: H2O

Target: CMV

• Artikelnummer: MEXHY-P99900-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99900-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated